💰SWF – Sovereign Wealth Fund

💰SWF – Sovereign Wealth Fund

Temasek Holdings Invests in JW Therapeutics

JW Therapeutics (Shanghai) Co., Ltd (JW Therapeutics), a clinical stage biopharmaceutical company, raised US$ 90 million in a Series A round.

JW Therapeutics was formed in 2016 by Juno Therapeutics and WuXi AppTec Group to focus on leading cell-based therapy technologies.

Lead investors in the Series A round include Temasek Holdings,

Sequoia Capital China,

and YuanMing Capital.

Other investors in the round include

Oriza Seed Capital,

Yipu Capital,

AVICT Global Holdings,

and existing investors WuXi AppTec Group, and Juno Therapeutics.

SWFI – Sovereign Wealth Fund Institute